Sustainable Development Acquisition I Corp. - Quarter Report: 2022 September (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(MARK ONE)
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarter ended September 30, 2022
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from _________ to _________
Commission file number: 001-40002
Sustainable Development Acquisition I Corp.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
|
85-4353398
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
5701 Truxtun Avenue, Suite 201
Bakersfield, California
|
93309
|
|
(Address of principal executive offices)
|
(Zip Code)
|
(323) 329-8221
(Issuer’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one redeemable warrant
|
SDACU
|
|
||
Shares of Class A common stock included as part of the units
|
SDAC
|
|
||
Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
|
SDACW
|
|
Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large
accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
|
☐ |
Accelerated filer
|
☐ |
Non-accelerated filer
|
☒ |
Smaller reporting company
|
☒ |
Emerging growth company
|
☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐
As of November 14, 2022, there were 31,625,000 Class A common stock, $0.0001 par value and 7,906,250
Class B, $0.0001 par value, issued and outstanding.
SUSTAINABLE DEVELOPMENT ACQUISITION I CORP.
FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2022
Page
|
||
1 | ||
1 | ||
1 | ||
2 | ||
3
|
||
4
|
||
5
|
||
16
|
||
19 |
||
19 |
||
21 | ||
21
|
||
21
|
||
22 | ||
22 | ||
22 | ||
22 | ||
22 | ||
23
|
ITEM 1. |
INTERIM FINANCIAL STATEMENTS
|
SUSTAINABLE DEVELOPMENT ACQUISITION I CORP.
September 30,
2022
(Unaudited)
|
December 31,
2021
|
|||||||
Assets:
|
||||||||
Cash
|
$
|
55,423
|
$
|
1,013,843
|
||||
Prepaid Expenses
|
217,933
|
577,500
|
||||||
Due from related party
|
7,429 | - | ||||||
Total current assets
|
280,785
|
1,591,343
|
||||||
Prepaid expenses – non-current portion
|
- | 54,418 | ||||||
Marketable securities held in Trust Account
|
318,009,009
|
316,273,116
|
||||||
Total Assets
|
$
|
318,289,794
|
$
|
317,918,877
|
||||
Liabilities, Common Stock Subject to Redemption, and Stockholders’ Deficit
|
||||||||
Accrued offering costs and expenses
|
$
|
661,231
|
$
|
780,704
|
||||
Income Tax Payable
|
295,709 | - | ||||||
Total Current Liabilities
|
956,940
|
780,704
|
||||||
Deferred underwriting fee
|
10,631,250
|
10,631,250
|
||||||
Warrant liability
|
1,022,584
|
14,878,193
|
||||||
Total liabilities
|
12,610,774
|
26,290,147
|
||||||
Commitments and Contingencies
|
||||||||
Common stock subject to possible redemption, 0.0001
par value, 31,625,000 stock at redemption value of $10.04 and $10.00 per share at September 30, 2022
and December 31, 2021, respectively
|
317,359,797
|
316,250,000
|
||||||
Stockholders’ Deficit:
|
||||||||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none
issued and outstanding
|
-
|
-
|
||||||
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; none
issued and outstanding at September 30, 2022 and December 31, 2021
|
-
|
-
|
||||||
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 7,906,250
shares issued and outstanding at September 30, 2022 and December 31, 2021
|
791
|
791
|
||||||
Additional paid-in capital
|
-
|
-
|
||||||
Accumulated deficit
|
(11,681,568
|
)
|
(24,622,061
|
)
|
||||
Total Stockholders’ Deficit
|
(11,680,777
|
)
|
(24,621,270
|
)
|
||||
Total Liabilities, Common Stock Subject to Redemption, and Stockholders’ Deficit
|
$
|
318,289,794
|
$
|
317,918,877
|
The accompanying notes are an integral part of these unaudited condensed financial statements.
SUSTAINABLE DEVELOPMENT ACQUISITION I CORP.
(UNAUDITED)
|
For the Three Months Ended
September 30,
|
For the Nine
Months Ended
September 30,
|
||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
|
||||||||||||||||
Operating costs
|
$
|
451,445
|
$ | 201,925 |
$
|
1,245,503
|
$ | 747,127 | ||||||||
Loss from Operations
|
(451,445
|
)
|
(201,925 | ) |
(1,245,503
|
)
|
(747,127 | ) | ||||||||
|
||||||||||||||||
Other income (expenses):
|
||||||||||||||||
Interest earned on marketable securities held in Trust Account
|
1,390,879
|
6,499 |
1,735,893
|
15,256 | ||||||||||||
Offering costs allocated to warrants
|
-
|
- |
-
|
(1,027,907 | ) | |||||||||||
Excess of fair value over cash received for private placement
warrants
|
-
|
- |
-
|
(1,939,600 | ) | |||||||||||
Change in fair value of warrant liability
|
1,017,581
|
8,163,756 |
13,855,609
|
12,472,773 | ||||||||||||
Total other income, net
|
2,408,460
|
8,170,255 |
15,591,502
|
9,520,522 | ||||||||||||
|
||||||||||||||||
Income before provision for income taxes
|
1,957,015 | 7,968,330 | 14,345,999 | 8,773,395 | ||||||||||||
Provision for income taxes
|
(281,402 | ) | - | (295,709 | ) | - | ||||||||||
Net income
|
$
|
1,675,613
|
$ | 7,968,330 |
$
|
14,050,290
|
$ | 8,773,395 | ||||||||
Weighted average shares outstanding, Class A common stock
|
31,625,000
|
31,625,000 |
31,625,000
|
26,991,300 | ||||||||||||
Basic and diluted net income per share, Class A common
stock
|
$
|
0.04
|
$ | 0.20 |
$
|
0.36
|
$ | 0.25 | ||||||||
Weighted average shares outstanding, Class B common stock
|
7,906,250
|
7,906,250 |
7,906,250
|
7,755,151 | ||||||||||||
Basic and diluted net income per share, Class B common stock
|
$
|
0.04
|
$ | 0.20 |
$
|
0.36
|
$ | 0.25 |
The accompanying notes are an integral part of these unaudited condensed financial statements.
SUSTAINABLE DEVELOPMENT ACQUISITION I CORP.
(UNAUDITED)
THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022
Class A
Common Stock
|
Class B
Common Stock
|
Additional
Paid-in
|
Accumulated |
Total
Stockholder’s
|
||||||||||||||||||||||||
Stock
|
Amount
|
Stock
|
Amount
|
Capital
|
Deficit
|
Deficit
|
||||||||||||||||||||||
Balance as of
December 31, 2021
|
-
|
$
|
-
|
7,906,250
|
$
|
791
|
$
|
-
|
$
|
(24,622,061
|
)
|
$
|
(24,621,270
|
)
|
||||||||||||||
Net income
|
-
|
-
|
-
|
-
|
-
|
6,991,287
|
6,991,287
|
|||||||||||||||||||||
Balance as of
March 31, 2022
|
-
|
$
|
-
|
7,906,250
|
$
|
791
|
$
|
-
|
$
|
(17,630,774
|
)
|
$
|
(17,629,983
|
)
|
||||||||||||||
Remeasurement of common stock subject to possible redemption
|
- | - | - | - | - | (53,823 | ) | (53,823 | ) | |||||||||||||||||||
Net income
|
-
|
-
|
-
|
-
|
-
|
5,383,390
|
5,383,390
|
|||||||||||||||||||||
Balance as of June
30, 2022
|
-
|
$
|
-
|
7,906,250
|
$
|
791
|
$
|
-
|
$
|
(12,301,207
|
)
|
$
|
(12,300,416
|
)
|
||||||||||||||
Remeasurement of common stock subject to possible redemption
|
- | - | - | - | - | (1,055,974 | ) | (1,055,974 | ) | |||||||||||||||||||
Net income | - | - | - | - | - | 1,675,613 | 1,675,613 | |||||||||||||||||||||
Balance as of September 30, 2022
|
- | $ | - | 7,906,250 | $ |
791 | $ | - | $ | (11,681,568 | ) | $ | (11,680,777 | ) |
THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021
Class A
Common Stock
|
Class B
Common Stock
|
Additional
Paid-in
|
Accumulated |
Total
Stockholder’s
|
||||||||||||||||||||||||
Stock
|
Amount
|
Stock
|
Amount
|
Capital
|
Deficit
|
Deficit
|
||||||||||||||||||||||
Balance as of
December 31, 2020
|
-
|
$
|
-
|
7,906,250
|
$
|
791
|
$
|
24,209
|
$
|
(2,412
|
)
|
$
|
22,588
|
|||||||||||||||
Net income
|
-
|
-
|
-
|
-
|
-
|
9,306,785
|
9,306,785
|
|||||||||||||||||||||
Remeasurement of common stock subject to possible redemption
|
-
|
-
|
-
|
-
|
(24,209
|
)
|
(35,035,527
|
)
|
(35,059,736
|
)
|
||||||||||||||||||
Balance as of March 31, 2021
|
-
|
$
|
-
|
7,906,250
|
$
|
791
|
$
|
-
|
$
|
(25,731,154
|
)
|
$
|
(25,730,363
|
)
|
||||||||||||||
Net loss
|
-
|
-
|
-
|
-
|
-
|
(8,501,720
|
)
|
(8,501,720
|
)
|
|||||||||||||||||||
Balance as of June 30, 2021
|
-
|
$
|
-
|
7,906,250
|
$
|
791
|
$
|
-
|
$
|
(34,232,874
|
)
|
$
|
(34,232,083
|
)
|
||||||||||||||
Net income | - | - | - | - | - | 7,968,330 | 7,968,330 | |||||||||||||||||||||
Balance as of September 30, 2021
|
- | $ |
- | 7,906,250 | $ |
791 | $ |
- | $ |
(26,264,544 | ) | $ |
(26,263,753 | ) |
The accompanying notes are an integral part of these unaudited condensed financial statements.
SUSTAINABLE DEVELOPMENT ACQUISITION I CORP.
(UNAUDITED)
|
For the Nine
Months Ended
September 30, 2022
|
For the Nine
Months Ended
September 30, 2021
|
||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$
|
14,050,290
|
$
|
8,773,395
|
||||
Adjustments to reconcile net income to net cash used in operating activities:
|
||||||||
Interest earned on marketable securities held in Trust Account
|
(1,735,893
|
)
|
(15,256
|
)
|
||||
Offering costs allocated to warrants
|
-
|
1,027,907
|
||||||
Excess of fair value over cash received for private placement warrants
|
-
|
1,939,600
|
||||||
Change in fair value of warrant liability
|
(13,855,609
|
)
|
(12,472,773
|
)
|
||||
Changes in operating assets and liabilities:
|
||||||||
Prepaid expenses
|
413,985
|
(781,879
|
)
|
|||||
Due from related party
|
(7,429 | ) | - | |||||
Accrued expenses
|
(119,473
|
)
|
173,450
|
|||||
Income Tax Payable
|
295,709 | - | ||||||
Net cash used in operating activities
|
(958,420
|
)
|
(1,355,556
|
)
|
||||
|
||||||||
Cash Flows from Investing Activities:
|
||||||||
Investment of cash in Trust Account
|
-
|
(316,250,000
|
)
|
|||||
Net cash used in investing activities
|
-
|
(316,250,000
|
)
|
|||||
|
||||||||
Cash Flows from Financing Activities:
|
||||||||
Proceeds from sale of Units, net of underwriting discounts
|
-
|
310,175,000
|
||||||
Proceeds from sale of Private Warrants
|
-
|
9,325,000
|
||||||
Proceeds from issuance of promissory note to Sponsor
|
-
|
121,228
|
||||||
Payments on promissory issued to Sponsor
|
-
|
(136,678
|
)
|
|||||
Payment of deferred offering costs
|
-
|
(589,730
|
)
|
|||||
Net cash provided by financing activities
|
-
|
318,894,820
|
||||||
|
||||||||
Net change in cash
|
(958,420
|
)
|
1,289,264
|
|||||
Cash, beginning of period
|
1,013,843
|
-
|
||||||
Cash, end of the period
|
$
|
55,423
|
$
|
1,289,264
|
||||
|
||||||||
Supplemental disclosure of cash flow information:
|
||||||||
Accretion of Class A stock subject to redemption |
$ | 1,109,797 | $ | 35,059,736 | ||||
Deferred underwriters’ discount payable charged to additional paid-in capital
|
$
|
-
|
$
|
10,631,250
|
||||
Initial classification of warrant liability |
$ | - | $ | 30,018,225 |
The accompanying notes are an integral part of these unaudited condensed financial statements.
Note 1 - Organization and Business Operations
Sustainable Development Acquisition I Corp. (the “Company”) is a
newly organized blank check company incorporated as a Delaware corporation on December 16, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (“Business Combination”).
As of September 30, 2022, the Company had not commenced any operations. All activity through September 30, 2022 relates to the Company’s formation and the Initial
Public Offering (“IPO”) which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the
earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.
The registration statement for the Company’s IPO was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on February 4, 2021 (the
“Effective Date”). On February 9, 2021, the Company consummated the IPO of 31,625,000 units (the “Units”) and, with
respect to the shares of common stock included in the Units sold (the “Public Shares”), which included the full exercise by the underwriters of the over-allotment option to purchase an additional 4,125,000 Units, at $10.00
per Unit, generating gross proceeds of $316,250,000, which is discussed in Note 3. Each Unit consists of one share of Class A common stock and
of one redeemable warrant to purchase one share of Class A common stock at a price of $11.50 per whole share.
Simultaneously with the closing of the IPO, the Company consummated the sale of 9,325,000 warrants (the “Private Placement Warrants”), at a price of $1.00 per Private Placement Warrant, in a private placement to Sustainable Development Sponsor, LLC, a Delaware limited
liability company (the “Sponsor”), generating gross proceeds of $9,325,000, which is discussed in Note 4.
Transaction costs of the IPO amounted to $17,404,019 consisting of $6,075,000 of
underwriting discount, $10,631,250 of deferred underwriting discount, and $697,769 of other offering costs.
Following the closing of the IPO on February 9, 2021, $316,250,000
($10.00 per Unit) from the net offering proceeds of the sale of the Units in the IPO and the sale of the Private Placement
Warrants was placed in a trust account (the “Trust Account”) and invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money
market funds meeting certain conditions of Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust
Account that may be released to the Company to pay its tax obligations, the net proceeds from the IPO and the sale of the Private Placement Warrants held in the Trust Account will not be released from the Trust Account until the
earliest of (a) the completion of the Company’s initial Business Combination, (b) the redemption of the Company’s public shares if the Company is unable to complete the initial Business Combination within 24 months from the closing of the IPO, subject to applicable law, and (c) the redemption of the Company’s
public shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation. The proceeds deposited in the Trust Account could become subject to the claims of the
Company’s creditors, if any, which could have priority over the claims of the Company’s public stockholders.
The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the
completion of the initial Business Combination either (i) in connection with a stockholder meeting called to approve the initial Business Combination or (ii) without a stockholder vote by means of a tender offer. The decision as to
whether the Company will seek stockholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their shares
for a pro rata share of the aggregate amount then on deposit in the Trust Account (initially approximately $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax
obligations).
The Company will have only 24 months from February 9, 2021, the closing of the IPO, to complete an initial Business Combination (the “Combination Period”). However, if the Company does not complete a Business Combination within the Combination Period, the Company will redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the Trust Account, equal to the aggregate amount then on deposit in the Trust Account including interest earned on
the funds held in the Trust Account and not previously released to the Company to pay its franchise and income taxes (less up to $100,000
of interest to pay dissolution expenses), divided by the number of then outstanding public shares, subject to applicable law and as further described in the registration statement, and then seek to dissolve and liquidate.
The Company’s initial
stockholders have agreed to (i) waive their redemption rights with respect to any founder shares and public shares they hold in connection with the completion of the initial Business Combination, (ii) waive their redemption rights
with respect to any founder shares and public shares they hold in connection with a stockholder vote to approve an amendment to the Company’s
amended and restated certificate of incorporation, (iii) waive their rights to liquidating distributions from the Trust Account with respect to any founder shares they hold if the Company fails to complete the initial Business
Combination within the Combination Period, and (iv) vote any founder shares and any public shares held by them in favor of the Company’s
initial Business Combination.
The Company’s Sponsor has agreed that it will be liable to the
Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target
business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i)
$10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the
liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable), nor will it apply to any
claims under the Company’s indemnity of the underwriters of the Proposed Public Offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked its Sponsor to reserve for
such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believes that the Company’s Sponsor’s only assets are securities of the
Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations.
Liquidity, Capital Resources and Going Concern
As of September 30, 2022, the Company had approximately $55,423 in its operating bank account and working capital of approximately $473,057 (adjusted for amounts available under the Convertible Note (as defined below) and amounts available for withdraw from the
trust for franchise and income tax obligations).
The Company’s liquidity needs up to February 9, 2021 had been satisfied through a capital contribution from the Sponsor of $25,000 (see Note 5)
for the founder shares and the loan under an unsecured promissory note from the Sponsor of $136,678 (see Note 5). The promissory note from the Sponsor was outstanding at February 9, 2021, and paid in full as of February 11, 2021 (see Note 5). Subsequent to the consummation of the IPO, the Company’s liquidity needs have been satisfied through the net proceeds from the
consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor, or certain of our
officers and directors may, but are not obligated to, provide us working capital loans. On August 23, 2022, the Company entered into a $500,000
promissory note agreement (the “Convertible Note”) with the Sponsor. The Convertible Note is payable upon the consummation of initial business combination or convertible into warrants at a price of $1.00 at the Sponsor’s discretion. The Convertible Note provides up to $500,000 in funds to be drawn against it. The Convertible Note does not accrue interest. As of September 30, 2022, there were no amounts outstanding under any working capital loans
other than the Convertible Note.
If the Company does not consummate an initial business combination
by February 9, 2023, there will be a mandatory liquidation and subsequent dissolution of the Company. In connection with the Company’s
assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements - Going
Concern,” management has determined that the liquidity condition due to insufficient working capital and mandatory liquidation, should an initial business combination not occur, and potential subsequent dissolution raises
substantial doubt about the Company’s ability to continue as a going concern for at least one year from the date that these financial statements are issued. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after
February 9, 2023. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a
going concern.
Risks and Uncertainties
Management is continuing to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that it could have a negative effect on the Company’s financial
position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that
might result from the outcome of this uncertainty.
In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this
action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not
determinable as of the date of these financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements.
Inflation Reduction Act of 2022
On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among
other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations
occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value
of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair
market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and
other guidance to carry out and prevent the abuse or avoidance of the excise tax.
Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or
otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors,
including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or
other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of
regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been
determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.
Note 2 - Significant Accounting Policies
Basis of Presentation
The
accompanying financial statements of the Company are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and
Exchange Commission (“SEC”). In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are necessary to present fairly the financial position, and the results of its operations and
its cash flows.
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the
“JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to
comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy
statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards
until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or
revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to
opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the
Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company
which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of financial statements in
conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the
reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original
maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021.
Marketable Securities Held in Trust Account
As of September 30, 2022, substantially all of the assets held in the Trust Account were held in money market funds which invest in
U.S. Treasury securities. The Company accounts for its investments within the Trust Account under ASC 320 “Investments – Debt Securities.” Under ASC 320, all of
the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the
change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in
Trust Account are determined using available market information (see Note 8). During the three and nine months ended September 30, 2022 and 2021, the Company did not withdraw any of the interest income from the Trust Account to pay
its tax obligations.
Warrant Liabilities
The Company evaluated the Public Warrants and Private Placement
Warrants (collectively, “Warrants”, which are discussed in Note 3, Note 4 and Note 8) in accordance with Accounting Standards Codification (“ASC”) 815-40, “Derivatives and Hedging - Contracts in Entity’s
Own Equity”, and concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a
derivative as contemplated in ASC 815, the Warrants are recorded as derivative liabilities on the Balance Sheets and measured at fair value at inception (on the date of the IPO) and at each
reporting date in accordance with ASC 820, “Fair Value Measurement”, with changes in fair value recognized in the Statements of Operations in the period of the change.
Offering Costs Associated with the Initial Public Offering
The Company complies with the requirements of ASC 340-10-S99-1.
Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the
separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, and
presented as non-operating expenses in the statement of operations. Offering costs associated with the Class A common stock were charged to temporary equity upon the completion of the Initial Public Offering.
Common Stock Subject to Possible Redemption
All of the 31,625,000 Class A Common Stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such public shares in connection with the
Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s second amended and restated certificate of incorporation. In accordance with the SEC and its staff’s guidance on redeemable
equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent
equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly, at September 30, 2022 and December 31, 2021, all shares of Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets.
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in
the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit.
The Class A common stock subject to possible redemption reflected
on the balance sheet as of September 30, 2022 and December 31, 2021 is reconciled
in the following table:
Gross Proceeds
|
$
|
316,250,000
|
||
Less:
|
||||
Proceeds allocated to Public Warrants
|
(18,753,625
|
)
|
||
Class A common stock issuance costs
|
(16,306,111
|
)
|
||
Plus:
|
||||
Remeasurement of carrying value to redemption value
|
35,059,736
|
|||
Class A common stock subject to possible redemption at December 31, 2021
|
$
|
316,250,000
|
||
Plus: | ||||
Remeasurement of carrying value to redemption value |
1,109,797 | |||
Class A common stock subject to possible redemption at September 30, 2022 | $ |
317,359,797 |
Share Based Compensation
The Company complies with ASC Topic 718 “Compensation - Stock Compensation” regarding interests in founder shares transferred by the Sponsor to directors
of the Company as compensation., which are described in Note 5.
The interests in the Founder Shares effectively vest upon the Company completing the initial Business
Combination and compensation expense will be recorded accordingly at that date based upon the initial grant date fair value, the determination of which represents a significant estimate. The grant date fair value is based upon an
option pricing model.
The Founders Shares were granted subject to a performance condition (i.e., consummation of the Business
Combination). Compensation expense related to the Founders Shares will be recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance.
As of September 30, 2022, the Company determined that a Business Combination is not
considered probable, and therefore no stock-based compensation expense has been recognized. Stock-based compensation will be recognized at the date a Business Combination is considered probable (i.e., upon completion of a Business
Combination) in an amount equal to the number of Founders Shares that ultimately vest multiplied times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the
Founders Shares.
Income Taxes
The
Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed
financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be
established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2022 and December 31, 2021, the Company’s deferred tax asset had a full valuation allowance
recorded against it.
Our
effective tax rate was 14% and 0.00% for the three months ended September 30, 2022 and 2021, respectively, and 2.06% and 0.00% for the nine months ended September 30,
2022 and 2021, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three
and nine months ended September 30, 2022 and 2021, due to changes in fair value in warrant liability and the valuation allowance on the deferred tax assets.
ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for
financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
The Company recognizes accrued interest and penalties related to
unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently
not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company has identified the United States as its
only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among
various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income Per Share
The Company complies with accounting and disclosure requirements of FASB
ASC Topic 260, “Earnings Per Share”. Net income per share is computed by dividing net income by the weighted average number of
shares of common stock outstanding during the period. The Company has two classes of shares, Class A Common Stock and Class B Common Stock. Earnings and losses are shared pro rata between the two classes of shares. The Company has not considered the effect of warrants sold
in the Initial Public Offering and the private placement to purchase 25,137,500 shares of Class A common stock in the calculation of diluted income per share, since the exercise of the warrants is contingent upon the occurrence of future events. As a result, diluted net income per common share is the same
as basic net income per common share for the years presented.
Basic and diluted net income per common share for Class A common stock and Class B common stock is calculated by dividing net income
attributable to the Company by the weighted average number of shares of Class A common stock and Class B common stock outstanding, allocated proportionally to each class of common stock.
Reconciliation of Net Income per Share
The Company’s net
income is adjusted for the portion of net income that is allocable to each class of common stock. The allocable net income is calculated by multiplying net income by the ratio of weighted average number of shares outstanding
attributable to Class A and Class B common stock to the total weighted average number of shares outstanding for the period. Accordingly, basic and diluted income per common share is calculated as follows:
For the Three Months Ended
September 30,
|
For the Nine Months Ended
September 30,
|
|||||||||||||||
2022 | 2021 |
2022 | 2021 | |||||||||||||
Class A Common Stock
|
||||||||||||||||
Net income allocable to
Class A common stock
|
$
|
1,340,490
|
$ | 6,374,664 |
$
|
11,240,232
|
$ | 6,815,238 | ||||||||
Basic and diluted
weighted average shares outstanding
|
31,625,000
|
31,625,000 |
31,625,000
|
26,991,300 | ||||||||||||
Basic and diluted net
income per common share
|
$
|
0.04
|
$ | 0.20 |
$
|
0.36
|
$ | 0.25 | ||||||||
Class B Common Stock
|
||||||||||||||||
Net income allocable to
Class B common stock
|
$
|
335,123
|
$ | 1,593,666 |
$
|
2,810,058
|
$ | 1,958,157 | ||||||||
Basic and diluted
weighted average shares outstanding
|
7,906,250
|
7,906,250 |
7,906,250
|
7,755,151 | ||||||||||||
Basic and diluted net
income per common share
|
$
|
0.04
|
$ | 0.20 |
$
|
0.36
|
$ | 0.25 |
Fair Value of Financial Instruments
The Company follows the guidance in ASC 820, “Fair Value Measurement,” for its financial assets and liabilities that are re-measured and reported at fair value at each reporting
period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.
The fair
value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities
in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained
from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and
liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
Level 1 -
|
Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block
discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.
|
Level 2 -
|
Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets,
(iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.
|
Level 3 -
|
Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
|
See Note 8 for additional information on assets and liabilities measured at fair value.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at
times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Recent Accounting Pronouncements
In August 2020, the FASB issued ASU 2020-06, “Debt-Debt with Conversion and Other Options” (Subtopic 470-20) and “Derivatives and Hedging-Contracts in Entity’s Own Equity” (Subtopic 815-40): “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for
convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for scope exception, and it
simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.
Management does not believe that any recently
issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.
Note 3 - Initial Public Offering
Public Units
On February 9, 2021, the Company sold 31,625,000
Units, at a purchase price of $10.00 per Unit, which includes the full exercise by the underwriters of the over-allotment
option to purchase an additional 4,125,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one common
stock, and
of one redeemable warrant to purchase one common stock (the “Public Warrants”).Public Warrants
Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50
per share, subject to adjustment. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The warrants will become exercisable on the later of 30 days after the completion of the initial Business Combination or 12
months from the closing of the IPO, February 9, 2021, and will expire five years after the completion of the initial
Business Combination, or earlier upon redemption or liquidation.
In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital
raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20
per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Company’s Sponsor or its affiliates,
without taking into account any founder shares held by the Sponsor or its affiliates, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and
interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the
Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the
Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the
exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market
Value and the Newly Issued Price, the $18.00 per share redemption trigger price described adjacent to “Redemption of
warrants when the price per share of Class A common stock equals or exceeds $18.00” will be adjusted (to the nearest
cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described adjacent to the caption “Redemption of warrants when the price per share of Class A
common Stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market
Value and the Newly Issued Price.
The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant
and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective and a current prospectus
relating thereto is current. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has
been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In no event will the Company be required to net cash settle any warrant. In the event that
a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the share of Class A common stock underlying such
unit.
Redemption of Warrants When the Price per Class A Common Stock Equals or Exceeds $18.00
Once the warrants become exercisable, the Company may redeem the outstanding warrants:
● |
in whole and not in part;
|
● |
at a price of $0.01 per warrant;
|
● |
upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and
|
● |
if, and only if, the last reported sale price of the Class A common stock for any 20 trading days within a 30-trading day period ending (the “Reference Value”) trading days before the Company sends the
notice of redemption to the warrant holders equals or exceeds $18.00
per share (as adjusted for stock sub-divisions, stock capitalizations, reorganizations, recapitalizations and the like).
|
Redemption of Warrants When the Price per Class A Common Stock Equals or Exceeds $10.00
Once the warrants become exercisable, the Company may redeem the outstanding warrants:
● |
in whole and not in part;
|
● |
at $0.10
per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to
exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the “fair market value” of the Class A common stock (as defined below in the immediately following
paragraph) except as otherwise described below;
|
● |
if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for stock sub-divisions, stock capitalizations, reorganizations, recapitalizations and the like); and
|
● |
if the Reference Value is less than $18.00 per share (as adjusted for stock sub-divisions, stock capitalizations, reorganizations, recapitalizations and the like), the private placement
warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.
|
If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the
60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an
effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act
or another exemption. In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Class A common stock equal to the lesser of (A) the quotient obtained by dividing (x) the product of
the number of shares of Class A common stock underlying the warrants, multiplied by the excess of the “fair market value” of the Class A common stock over the exercise price of the warrants by (y) the fair market value and (B) 0.361 per whole warrant. The “fair market value” as used in this paragraph shall mean the average last reported sale price of the Class A
common stock for the
trading days ending on the trading day prior to the date on which the notice of exercise is received by the warrant agent. If that exemption, or another exemption, is not available,
holders will not be able to exercise their warrants on a cashless basis.Note 4 - Private Placement
Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 9,325,000 Private Warrants at a price of $1.00
per Private Warrant, for an aggregate purchase price of $9,325,000, in a private placement. Each Private Warrant entitles the holder to purchase one
share of common stock at a price of $11.50 per share. A portion of the proceeds from the private placement was added
to the proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Warrants will expire worthless.
The Private Warrants are identical to the Public Warrants sold in the IPO except that the Private Warrants, so long as they are held
by the initial stockholders or its permitted transferees, (i) they will not be redeemable by the Company for cash, (ii) they (including the Class A common stock issuable upon exercise of these warrants) may not, subject to certain
limited exceptions, be transferred, assigned or sold until 30 days after the completion of the Company’s initial Business
Combination, and (iii) they may be exercised by the holders on a cashless basis. If the Private Warrants are held by holders other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by
the Company and exercisable by the holders on the same basis as the warrants included in the Units being sold in the IPO.
Note 5 - Related Party Transactions
Founder Shares
On December 18, 2020, the Company’s initial stockholders purchased an aggregate of 7,187,500 shares of Class B common stock (the
“Founder Shares”) for a capital contribution of $25,000. On February 4, 2021, the
Company effected a stock dividend of underwriters’ of a share of Class B common stock for each outstanding share of Class B
common stock, resulting in 7,906,250 shares of Class B common stock being issued and outstanding, including an
aggregate of up to 1,031,250 shares subject to forfeiture if the over-allotment option was not exercised by the
underwriters in full. As a result of the election to fully exercise their over-allotment option, on February 9, 2021, the 1,031,250 shares are no longer subject to forfeiture. Prior to the stock dividend on February 4, 2021, shares outstanding included up to 937,500 of Founder Shares subject to forfeiture by the Sponsor if the over-allotment option was not exercised in full or in part by the
underwriters.
In January 2021, the Sponsor transferred 25,000 Founder Shares to each of the Company’s three independent directors, as an
inducement to serve as directors of the Company, for a sales price of $0.003 per share, or an aggregate of $261 (the “purchase price”). The estimated fair value of the Founder Shares granted to the Company’s director nominees, was approximately $518,062, or $6.91 per
share, which was calculated using a valuation model that takes into account various assumptions such as the probability of successfully completing a business combination and various other factors. The Company will record the fair
value of the transferred shares as director compensation expense upon consummation of an initial business combination, in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 718 “Compensation-Stock
Compensation”, which requires deferral of the expense recognition until after the performance condition is achieved, if the performance condition is a business combination or similar liquidity event. The transferred shares have the
same terms and restrictions as the Founder Shares held by the Sponsor.
The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares (subject to certain limited exceptions)
until the earlier to occur of (i) one year after the completion of the Company’s initial Business Combination or (ii) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar
transaction after the initial Business Combination that results in all of the Company’s stockholders having the right to exchange their Class A common stock for cash, securities or other
property (the “Lock-up”). Notwithstanding the foregoing, if (A) the last reported sales price of the Company’s Class A common stock equals or
exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the
like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the
initial Business Combination or (B) the Company consummates a transaction after the initial Business Combination which results in its stockholders having the right to exchange their shares for cash, securities or other property, the
Founder Shares will be released from the Lock-up.
Promissory Note - Related Party
On December 18, 2020, the Company issued an unsecured promissory note to the Sponsor for an aggregate of up to $300,000 to cover expenses related to the IPO. This loan was non-interest bearing and payable on the earlier of July 15, 2021 or the
completion of the IPO. As of February 9, 2021, the Company has drawn down $136,678 under the promissory note. On February 11,
2021, the Company paid the $136,678 balance on the note.
Related Party Loans
In order
to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be
required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital
Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working
Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $2,000,000 of
such Working Capital Loans may be convertible into warrants at a price of $1.00 per warrant at the option of the lender.
The warrants would be identical to the Private Placement Warrants, including as to exercise price, exercisability and exercise period.
On August 23, 2022, the Company entered into a
$500,000 promissory note (the “Convertible Note”) agreement with the Sponsor. The Convertible Note is payable upon the
consummation of initial business combination or convertible into warrants at a price of $1.00 at the Sponsor’s
discretion. The Convertible Note provides up to $500,000 in funds to be drawn against it. The Convertible Note does not
accrue interest. At September 30, 2022 and December 31, 2021, other than the Convertible Note, there was no outstanding balance on the Working Capital Loans.
Note 6 - Commitments and Contingencies
Underwriting Agreement
The underwriter had a 45-day option from
the date of the IPO to purchase up to an aggregate of 4,125,000 additional Units at the public offering price less the
underwriting commissions to cover over-allotments, if any. On February 9, 2021, the underwriter fully exercised its over-allotment option.
Upon consummation of the IPO on February 9, 2021, the underwriters were paid a cash underwriting fee of 2.0% of the gross proceeds of the IPO, or $6,075,000
in the aggregate.
The underwriters are entitled to a deferred underwriting fee of $0.35 per unit, or $10,631,250 in the aggregate,
excluding 1,250,000 units purchased by an affiliate of the Sponsor upon which the underwriters are not entitled to a fee.
The deferred fee will be payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes an initial Business Combination, subject to the terms of the underwriting agreement.
Registration Rights
The holders of the Founder Shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital
Loans will have registration rights to require the Company to register a sale of any of its securities held by them pursuant to a registration rights agreement to be signed prior to or on the effective date of the Proposed Public
Offering. These holders will be entitled to make up to three demands, excluding short form registration demands, that the
Company registers such securities for sale under the Securities Act. In addition, these holders will have “piggy-back” registration rights to include their securities in other registration statements filed by the Company.
Note 7 - Stockholders’ Equity
Preferred Stock - The Company is authorized to issue a total of 1,000,000 preferred shares at par value of $0.0001 each. At September 30, 2022 and December 31, 2021, there were no preference shares issued or outstanding.
Class A Common Stock - The Company is authorized to issue a total of 100,000,000 shares of Class A common stock at
par value of $0.0001 each. At September 30, 2022 and December 31, 2021, there were no shares issued and outstanding, excluding 31,625,000 shares subject to possible redemption.
Class B Common stock - The Company is authorized to issue a total of 10,000,000 shares of Class B common stock at
par value of $0.0001 each. At September 30, 2022 and December 31, 2021,
there were 7,906,250 shares issued and outstanding.
The Company’s Sponsor, directors and officers have agreed not to
transfer, assign or sell their Founder Shares until the earlier to occur of (A) one year after the completion of the Company’s
initial Business Combination or (B) subsequent to the Company’s initial Business Combination, (x) if the reported closing price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading
day period commencing at least 150 days after the Company’s initial Business Combination, or (y) the date on which the
Company completes a liquidation, merger, capital stock exchange, or other similar transaction that results in all of its stockholders having the right to exchange their shares of common stock for cash, securities or other property.
The
shares of Class B common stock will automatically convert into shares of the Company’s Class A common stock at the time of its initial Business Combination on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights, as described herein. In the case that additional shares of Class A common stock or
equity-linked securities are issued or deemed issued in connection with the Company’s initial Business Combination, the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the
aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the
completion of the Proposed Public Offering, plus the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by
the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A
common stock issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent warrants issued to the Company’s Sponsor, officers or directors upon conversion of working capital loans;
provided that such conversion of Founder Shares will never occur on a less than one for one basis.
Holders of record of the Class A common stock and holders of record of the Class B common stock will vote together as a single class
on all matters submitted to a vote of the Company’s stockholders, with each share of common stock entitling the holder to one
vote except as required by law.
Note 8 - Fair Value Measurements
The following table presents information about the Company’s assets
and liabilities that are measured at fair value on a recurring basis at September 30, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
September 30,
|
Quoted
Prices In
Active
Markets
|
Significant
Other
Observable
Inputs
|
Significant
Other
Unobservable
Inputs
|
|||||||||||||
2022
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
|||||||||||||
Assets:
|
||||||||||||||||
U.S. Money Market held in Trust Account
|
$
|
318,009,009
|
$
|
318,009,009
|
$
|
-
|
$
|
-
|
||||||||
Liabilities:
|
||||||||||||||||
Public Warrants Liability
|
$
|
621,431
|
$
|
621,431
|
$
|
-
|
$
|
-
|
||||||||
Private Placement Warrants Liability
|
401,153
|
-
|
-
|
401,153
|
||||||||||||
$
|
1,022,584
|
$
|
621,431
|
$
|
-
|
$
|
401,153
|
The Warrants are accounted for as liabilities in accordance with ASC
815-40 and are presented within warrant liabilities on the balance sheet. The warrant
liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the statements of operations.
The Company established the initial fair value of the Public Warrants and Private Warrants on February 9, 2021, the date of the
Company’s Initial Public Offering, using a Monte Carlo simulation model. As of December 31, 2021, the fair value for the Private Warrants was estimated using a Monte Carlo simulation model, and the fair value of the Public
Warrants by reference to the quoted market price. The Public and Private Warrants were classified as Level 3 at the initial measurement date, and the Private Warrants were classified as Level 3 as of September 30, 2022 and
December 31, 2021, due to the use of unobservable inputs. The transfer from Level 3 to Level 1 for the Public Warrants occurred on March 31, 2021 due to the use of the observed trading price of the separated Public Warrants.
The following table presents the changes in Level 3 liabilities for the three and nine months ended September 30, 2022:
Fair Value at January 1, 2022
|
$
|
5,550,399
|
||
Change in fair value of public and private warrants
|
(2,722,959
|
)
|
||
Fair Value of private warrants at March 31, 2022
|
$
|
2,827,440
|
||
Change in fair value of public and private warrants
|
(2,052,275 | ) | ||
Fair Value of private warrants at June 30, 2022
|
$ | 775,165 | ||
Change in fair value of public and private warrants |
(374,012 | ) | ||
Fair Value of private warrants at September 30, 2022 |
$ | 401,153 |
The key inputs into the Monte Carlo simulation as of September 30, 2022 and December 31, 2021 were as follows:
Inputs
|
September 30,
2022
|
December 31,
2021
|
||||||
Risk-free interest rate
|
4.04
|
%
|
1.32
|
%
|
||||
Expected term remaining (years)
|
5.49
|
5.60
|
||||||
Expected volatility
|
1.3
|
%
|
10.7
|
%
|
||||
Stock price
|
$
|
9.84
|
$
|
9.74
|
Note 9 - Subsequent Events
The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any, other than the below,
subsequent events that would have required adjustment or disclosure in the financial statements.
The Company is currently in active discussions with an entity regarding a potential Business Combination (the “Potential Business Combination”), but
the Company’s board of directors believes that there will not be sufficient time before the February 4, 2023 deadline to complete the Potential Business Combination. Therefore, On November 4, 2022, the Company filed a preliminary
proxy statement in connection with a stockholders meeting (the “Extension Meeting”) to vote on a proposed extension of time for the Company to consummate a business combination from February 4, 2023 to August 12, 2023.
On October 11, 2022, Barclays Capital Inc. (“Barclays”) notified the Company that, subject to certain conditions, Barclays waives its entitlement
to the payment of its portion of any deferred compensation in connection with its role as underwriter in the Initial Public Offering.
ITEM 2. |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
References to the “Company,” “our,” “us” or “we” refer to Sustainable Development Acquisition I Corp. The following discussion and analysis of the Company’s financial condition and results of
operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes
forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected.
All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the
Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and
similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently
available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could
cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the U.S.
Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any
intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Recent Developments
The Company is currently in active discussions with an entity regarding a potential Business Combination (the “Potential Business Combination”),
but the Company’s board of directors believes that there will not be sufficient time before the February 4, 2023 deadline to complete the Potential Business Combination. Therefore, On November 4, 2022, the Company filed a preliminary proxy
statement in connection with a stockholders meeting (the “Extension Meeting”) to vote on a proposed extension of time for the Company to consummate a business combination from February 4, 2023 to August 12, 2023.
On October 11, 2022, Barclays Capital Inc. (“Barclays”) notified the Company that, subject to certain conditions, Barclays waives its
entitlement to the payment of its portion of any deferred compensation in connection with its role as underwriter in the Initial Public Offering.
Overview
We are a blank check company incorporated as a Delaware public benefit corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or
similar business combination with one or more businesses. We intend to effectuate our initial business combination using cash from the proceeds of our Initial Public Offering and the private placement of the private placement warrants, the proceeds
of the sale of our shares in connection with our initial business combination (pursuant to forward purchase agreements or backstop agreements we may enter into following the consummation of our Initial Public Offering or otherwise), shares issued
to the owners of the target, debt issued to banks or other lenders or the owners of the target, or a combination of the foregoing.
The registration statement for our IPO was declared effective on February 4, 2021. On February 9, 2021, we consummated the IPO of 31,625,000 units (including 4,125,000 units issued to the Underwriters pursuant to the
exercise in full of the over-allotment option granted to the Underwriters) (“Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $316.3
million, and incurring offering costs of approximately $17.4 million, inclusive of $10.6 million in deferred underwriting commissions.
Simultaneously with the closing of the IPO, we consummated the private placement (“Private Placement”) of 9,325,000 warrants at a price of $1.00 per warrant (“Private Placement Warrants” and, together with the
warrants included in the Units, the “Warrants”) to the Sponsor, generating gross proceeds of approximately $9.3 million.
Upon the closing of the IPO and the Private Placement on February 9, 2021, $316.3 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the IPO and the Private Placement were placed in a trust
account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. “government securities,” within the meaning of Section 2(a)(16) of the Investment Company Act of
1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act, which invest only in direct U.S. government
treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.
If we have not completed a Business Combination within 24 months from the closing of the IPO, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not
more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not
previously released to us to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as
stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and our board of directors,
liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
Results of Operations
For the three months ended September 30, 2022, we had a net income of approximately $1.7 million, which included a gain from the change in fair value of warrant liabilities of $1 million and interest income on
marketable securities of $1.4 million, offset by a loss from operations of $0.45 million and income tax provision of $0.28 million.
For the nine months ended September 30, 2022, we had a net income of approximately $14 million, which included a gain from the change in fair value of warrant liabilities of $13.9 million and interest income on
marketable securities of $1.7 million, offset by loss from operations of $1.2 million and a provision for income tax of $0.3 million.
For the three months ended September 30, 2021, we had a net income of approximately $8.0 million, which included a gain from the change in fair value of warrant liabilities of $8.2 million, offset by a loss from
operations of $0.2 million.
For the nine months ended September 30, 2021, we had a net income of approximately $8.8 million, which included a gain from the change in fair value of warrant liabilities of $12.5 million, offset by a loss from
operations of $0.7 million, offering cost expense allocated to warrants of $1.0 million, expense for excess in fair value over cash received for private placement warrants of $1.9 million.
Our business activities from inception to September 30, 2022 consisted primarily of our formation and completing our IPO, and since the offering, our activity has been limited to identifying and evaluating
prospective acquisition targets for a Business Combination.
Liquidity and Capital Resources
Until the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of Class B common stock by our Sponsor and advances from our Sponsor.
On February 9, 2021, we consummated our Initial Public Offering of 31,625,000 units (the “Units”), including 4,125,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional
Units. Each Unit consists of one share of Class A common stock, $0.0001 par value per share (the “Class A Common Stock”), and one-half of one redeemable warrant (the “Public Warrants”), each whole Public Warrant entitling the holder thereof to
purchase one share of Class A Common Stock at an exercise price of $11.50 per share, subject to adjustment. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $316,250,000 (before underwriting discounts and
commissions and offering expenses). Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 9,325,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant in a private placement to our
stockholders, generating gross proceeds of $9,325,000.
Following the Initial Public Offering, the full exercise of the over-allotment option, and the sale of the Private Placement Warrants, a total of $316,250,000 was placed in the Trust Account, and we had approximately
$3.2 million of cash held outside of the Trust Account and working capital of approximately $2.6 million. We incurred approximately $17.4 million in transaction costs, including $10.6 million of deferred underwriting fees that will be paid to the
underwriters from the amounts held in the Trust Account solely in the event the Company completes its initial Business Combination.
For the nine months ended September 30, 2022, net cash used in operating activities was approximately $1 million.
For the nine months ended September 30, 2021, net cash used in operating activities was approximately $1.4 million.
At September 30, 2022, we had cash held in the Trust Account of $318,009,009. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust
Account (less taxes payable (if applicable) and deferred underwriting commissions) and the proceeds from the sale of the forward purchase shares to complete our Business Combination. To the extent that our shares or debt is used, in whole or in
part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the post-Business Combination entity, make other acquisitions and pursue our
growth strategies.
At September 30, 2022, we had cash of $55,423 held outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due
diligence on prospective target businesses, travel to and from the offices, properties or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective
target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are
not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the
Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $2,000,000 of such loans may be convertible into warrants, at the price of $1.00 per warrant at the option of the lender. On
August 23, 2022, the Company entered into a $500,000 promissory note agreement with the Sponsor. The note is payable upon the consummation of initial business combination or convertible into warrants at a price of $1.00 at the Sponsor’s discretion.
The note provides up to $500,000 in funds to be drawn against it. The note does not accrue interest. As of September 30, 2022, other than the promissory note described above, there were no amounts outstanding under any working capital loan.
Going Concern
In connection with our assessment of going concern considerations in accordance with Financial Accounting Standards Board’s Accounting Standards Codification Topic 205-40, “Presentation of Financial Statements –
Going Concern,” we have until February 9, 2023, to consummate an initial business combination. It is uncertain that we will be able to consummate an initial business combination by this time. If an initial business combination is not consummated by
this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Additionally, it is uncertain that we will have sufficient liquidity to fund the working capital needs of the Company through February 9, 2023 or through
twelve months from the issuance of this report. We have determined that the liquidity condition and mandatory liquidation, should an initial business combination not occur, and potential subsequent dissolution raises substantial doubt about the
Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after February 9, 2023.
Contractual Obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities. The underwriters are entitled to a deferred fee of $0.35 per share, or $10,631,250 in the aggregate.
The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.
Critical Accounting Estimates
This management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these
financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our financial statements. On an ongoing
basis, we evaluate our estimates and judgments, including those related to fair value of financial instruments and accrued expenses. We base our estimates on historical experience, known trends and events and various other factors that we believe
to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates
under different assumptions or conditions.
Except as set forth below, there have been no significant changes in our critical accounting policies as discussed in our Annual Report on Form 10-K for the year ended December 31, 2021.
Recent Accounting Standards
In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible
Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that
are required for equity-linked contracts to qualify for scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 at January 1, 2021. Adoption of the ASU did not impact the
Company’s financial position, results of operations or cash flows.
Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our financial statements.
ITEM 3. |
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
Through September 30, 2022, our efforts have been limited to organizational activities, activities relating to our Initial Public Offering, and searching for a target business. We have engaged in
limited operations and have not generated any revenues. We have not engaged in any hedging activities since our inception. We do not expect to engage in any hedging activities with respect to the market risk to which we are exposed.
The net proceeds of our Initial Public Offering, including amounts in the trust account, have been invested in U.S. government treasury obligations with a maturity of 185 days or less or in
certain money market funds that invest solely in U.S. treasuries. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.
ITEM 4. |
CONTROLS AND PROCEDURES
|
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act
(the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that
information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding
required disclosure.
Evaluation of Disclosure Controls and Procedures
As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the
effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2022. Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures
were not effective as of September 30, 2022, due to the previous material weakness in our internal control over financial reporting related to accounting for complex financial instruments described in Item 4. Controls and Procedures included in our
Quarterly Report on Form 10-Q as filed with the SEC on May 25, 2021, and due to the restatements of our February 9, 2021, March 31, 2021, and June 30, 2021 financial statements (the “restatements”) regarding the classification of redeemable Class A
Shares, as described below, which combined, constitutes a material weakness in our internal control over financial reporting related to accounting for complex financial instruments. Additionally, management has identified a material weakness in
internal controls related to the accounting for fair value measurements including accruals of dividend income earned on marketable securities held in Trust Account. In light of these material weaknesses, we performed additional analysis as deemed
necessary to ensure that our unaudited interim financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, our Chief Executive Officer and Chief Financial Officer believes that the financial
statements included in this Quarterly Report on Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the period presented.
Regarding the restatements to the March 31, 2021, and June 30, 2021 quarterly financial statements included in the Company’s Form 10-Qs, as filed with the SEC on May 25, 2021 and August 20, 2021,
respectively, as well as the Company’s balance sheet included on the Company’s Form 8-K, as filed with the SEC on February 16, 2021, and restated on the Form 10-Q filed with the SEC on May 25, 2021, certain redemption provisions not solely within
the control of the Company require common stock subject to redemption to be classified outside of permanent equity. The Company had previously classified a portion of the Class A common stock in permanent equity. The Company restated its financial
statements to classify all Class A common stock as temporary equity and any related impact, as the threshold in its charter would not change the nature of the underlying shares as redeemable and thus would be required to be disclosed outside of
permanent equity.
It is noted that the non-cash adjustments to the financial statement do not impact the amounts previously reported for our cash and cash equivalents or total assets. In light of this material
weakness, we performed additional analysis as deemed necessary to ensure that our unaudited interim financial statements were prepared in accordance with U.S. generally accepted accounting principles.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during the quarter ended on
September 30, 2022 covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Our Chief Executive Officer and Chief Financial Officer performed additional accounting and financial analyses and other post-closing procedures including consulting with subject matter experts
related to the accounting for the Warrants. The Company’s management has expended, and will continue to expend, a substantial amount of effort and resources for the remediation and improvement of our internal control over financial reporting. While
we have processes to properly identify and evaluate the appropriate accounting technical pronouncements and other literature for all significant or unusual transactions, we have expanded and will continue to improve these processes to ensure that
the nuances of such transactions are effectively evaluated in the context of the increasingly complex accounting standards.
ITEM 1. |
LEGAL PROCEEDINGS.
|
None.
ITEM 1A. |
RISK FACTORS.
|
Factors that could cause our actual results to differ materially from those in this Quarterly Report include the risk factors described in our Annual Report of Form 10-K for the year ended
December 31, 2021. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed with the SEC other than described below.
Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate
and complete our initial business combination, and results of operations.
On March 30, 2022, the SEC issued proposed rules relating to, among other items, disclosures in business combination transactions involving SPACs and private operating companies; the financial
statement requirements applicable to transactions involving shell companies; the use of projections in SEC filings in connection with proposed business combination transactions; the potential liability of certain participants in proposed business
combination transactions; and the extent to which SPACs could become subject to regulation under the Investment Company Act of 1940, as amended, including a proposed rule that would provide SPACs a safe harbor from treatment as an investment
company if they satisfy certain conditions that limit a SPAC’s duration, asset composition, business purpose and activities. These rules, if adopted, whether in the form proposed or in a revised form, may increase the costs of and the time needed
to negotiate and complete an initial business combination, and may constrain the circumstances under which we could complete an initial business combination.
A new 1% U.S. federal excise tax could be imposed on us in connection with redemptions by us of our shares.
On August 16, 2022, the Inflation Reduction Act of 2022 (the “IRA”) was signed into federal law. The IRA provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including
redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its stockholders from which
shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to
net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”)
has been given authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of the excise tax; however, no guidance has been issued to date.
The IRA applies only to repurchases that occur after December 31, 2022. It is uncertain whether, and/or to what extent, the excise tax could apply to any redemptions of our public shares after December 31, 2022,
including any redemptions in connection with initial business combination or a liquidation in the event we do not consummate an initial business combination by February 4, 2023. Any redemption or other repurchase that occurs after December 31,
2022, in connection with a business combination or otherwise may be subject to the excise tax. Whether and to what extent we would be subject to the excise tax in connection with a business combination would depend on a number of factors, including
(i) the fair market value of the redemptions and repurchases in connection with the business combination, (ii) the structure of the business combination, (iii) the nature and amount of any private investment in public equity or other equity
issuances in connection with the business combination (or otherwise issued not in connection with the business combination but issued within the same taxable year of the business combination) and (iv) the content of regulations and other guidance
from the Treasury. In addition, because the excise tax would be payable by us, and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash
available on hand to complete a business combination and in our ability to complete a business combination.
ITEM 2. |
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
|
On February 9, 2021, we consummated our Initial Public Offering of 31,625,000 Units, including 4,125,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase
additional Units. There has been no material change in our planned use of the net proceeds from the initial public offering as described in our final prospectus filed with the SEC.
ITEM 3. |
DEFAULTS UPON SENIOR SECURITIES.
|
None.
ITEM 4. |
MINE SAFETY DISCLOSURES.
|
Not applicable.
ITEM 5. |
OTHER INFORMATION.
|
None.
ITEM 6. |
EXHIBITS.
|
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
No.
|
Description of Exhibit
|
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
|
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
|
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
101.INS*
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
|
101.CAL*
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
101.SCH*
|
Inline XBRL Taxonomy Extension Schema Document
|
101.DEF*
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
101.LAB*
|
Inline XBRL Taxonomy Extension Labels Linkbase Document
|
101.PRE*
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
104*
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
|
* |
Filed herewith.
|
** |
Furnished.
|
Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Sustainable Development Acquisition I Corp.
|
||
Date: November 14, 2022
|
/s/ Nicole Neeman Brady
|
|
Name:
|
Nicole Neeman Brady
|
|
Title:
|
Chief Executive Officer and Director
|
|
(Principal Executive Officer)
|
||
Date: November 14, 2022
|
/s/ Eric Techel
|
|
Name:
|
Eric Techel
|
|
Title:
|
Chief Financial Officer
|
|
(Principal Financial and Principal Accounting Officer)
|